Global Medical Transcription Calumet City, IL - 60409

Global Medical Transcription is categorized under Health Services in Calumet City, IL and active since 2008.

Global Medical Transcription was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 5614100 by the NAICS.

If you are seeking more information, feel free to contact Gertrude Martin, Owner at the company’s single location by writing to 379 Luella Avenue, Calumet City, Illinois IL 60409 or by phoning (708) 868-5373. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Global Medical Transcription
Contact Person: Gertrude Martin, Owner
Address: 379 Luella Avenue, Calumet City, Illinois 60409
Phone Number: (708) 868-5373
Website Address: gmtsinc.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Health Services
SIC Code: 8099
NAICS Code: 5614100
Share This Business:

Global Medical Transcription was started in 2008 to provide professional Health Services under the SIC code 8099 and NAICS code 5614100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Gertrude Martin, Owner for inquiries that concern Global Medical Transcription by calling the company number (708) 868-5373, as your correspondence is most welcome. Additionally, the physical location of the single location of Global Medical Transcription can be found at the coordinates 41.62605,-87.56753 as well as the street address 379 Luella Avenue in Calumet City, Illinois 60409.

For its online presence, you may visit Global Medical Transcription’s website at gmtsinc.com and engage with its social media outlets through on Twitter and on Facebook.